Charles River Labs Intl buy JPMorgan Chase & Co.
Start price
15.02.24
/
50%
€227.80
Target price
15.02.25
€259.70
Performance (%)
-22.89%
Price
11.09.24
€175.65
Summary
This prediction is currently active. The price of Charles River Labs Intl has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.89%. This prediction currently runs until 15.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Charles River Labs Intl | 2.063% | 2.063% |
iShares Core DAX® | 2.275% | 4.627% |
iShares Nasdaq 100 | 6.015% | 2.007% |
iShares Nikkei 225® | 4.456% | 3.598% |
iShares S&P 500 | 4.061% | 2.876% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $270.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€211.90
20.12.23
20.12.23
€246.65
20.12.24
20.12.24
-17.11%
11.09.24
11.09.24
Charles River Labs Intl
Start price
Target price
Perf. (%)
€198.20
10.08.23
10.08.23
€227.00
10.08.24
10.08.24
-7.39%
11.08.24
11.08.24